Researchers will soon undertake one of the largest-ever long-term clinical trials of a system designed to help regulate blood sugar levels of individuals with type 1 diabetes mellitus. If the ...
New technology that allows a University of Virginia-developed artificial pancreas system to adapt to users’ changing bodies – and lets users test changes to how the system operates – improved control ...
Diabetes is a chronic disease characterised by a failure of insulin to control blood glucose levels with two main types: type 1 and type 2. Diabetes is a global concern, with 783 million adults ...
With speculation about an artificial pancreas rising, the September edition of Evidenced-Based Diabetes Management looked at the three systems that were being considered by the FDA including the ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A fully ...
A new electronic implant system can help lab‑grown pancreatic cells mature and function properly, potentially providing a basis for novel, cell-based ...
Morning Overview on MSN
Nervous system caught actively fueling deadly pancreatic cancer growth
Pancreatic cancer has long been feared for its silence and speed, often spreading before symptoms push patients into the ...
For several years, JDRF-funded researchers at the University of Virginia Center for Diabetes Technology have been hard at work designing an artificial pancreas system that would allow individuals with ...
The global Artificial Pancreas Device System (APDS) market in terms of revenue was estimated to be worth $123.5 million in 2022 and is poised to reach $405.3 million by 2030, growing at a CAGR of 14.1 ...
Diabetes is on the rise worldwide. It is a permanent condition that requires care over a life time. To help manage it, an artificial pancreas system, which automatically measures blood sugar levels to ...
Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results